Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
- PMID: 38251467
- PMCID: PMC10755104
- DOI: 10.1016/j.ebiom.2023.104852
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
Conflict of interest statement
Declaration of interests We declare no competing interests.
Comment in
-
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?EBioMedicine. 2023 Dec;98:104853. doi: 10.1016/j.ebiom.2023.104853. Epub 2023 Oct 28. EBioMedicine. 2023. PMID: 38251468 Free PMC article. No abstract available.
Comment on
-
Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination.EBioMedicine. 2023 Sep;95:104743. doi: 10.1016/j.ebiom.2023.104743. Epub 2023 Aug 11. EBioMedicine. 2023. PMID: 37574375 Free PMC article.
References
-
- Donaldson S.L., Kosco M.H., Szakal A.K., Tew J.G. Localization of antibody-forming cells in draining lymphoid organs during long-term maintenance of the antibody response. J Leukoc Biol. 1986;40:147–157. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
